We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Benchmark Holdings Plc | LSE:BMK | London | Ordinary Share | GB00BGHPT808 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 44.10 | 44.10 | 45.90 | 0.00 | 08:08:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 169.74M | -23.15M | -0.0313 | -14.09 | 326.05M |
TIDMBMK
RNS Number : 8812T
Benchmark Holdings PLC
30 March 2021
30 March 2021
Benchmark Holdings plc
("Benchmark" or the "Company")
Listing of existing senior secured NOK bond ISIN NO 0010858210
Benchmark, the aquaculture biotechnology company, notifies that further to the announcement made on 13 June 2019, the Company has today listed its existing NOK 850 million senior secured floating rate bond (the "bond") on the Oslo Stock Exchange. The listing of the bond satisfies the last remaining condition under the terms of the bond. As previously announced, the bond has a coupon of three months NIBOR* + 5.25% p.a. with quarterly interest payments and matures in June 2023.
A copy of the prospectus which was approved by the NFSA, the Norwegian Financials Supervisory Authority, on 11th March 2021 is available at https://www.benchmarkplc.com/investors/documents-circulars/#documents
*The three month NIBOR (Norwegian Interbank Offered Rate) stood at 0.38% as at 29 March 2021.
Enquiries:
Benchmark Holdings plc Tel: +44(0) 20 3696 0630 Trond Williksen, CEO Septima Maguire, CFO Ivonne Cantu, Investor Relations Numis (Broker and NOMAD) Tel: +44(0) 20 7260 1000 James Black, Freddie Barnfield, Duncan Monteith MHP Communications Tel: +44(0) 20 3128 8742 Katie Hunt, Reg Hoare, Alistair de Kare-Silver benchmark@mhpc.com
About Benchmark
Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability. We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out. Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCUKRARAWUOUUR
(END) Dow Jones Newswires
March 30, 2021 02:00 ET (06:00 GMT)
1 Year Benchmark Chart |
1 Month Benchmark Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions